Let’s Talk About the Ethics of Germline Modification
By Gregor Wolbring,
Impact Ethics
| 05. 27. 2015
Untitled Document
Human germline genetic modification, which involves making genetic changes that will be passed on to future generations, is once again in the news.
Mid-March 2015, in anticipation of a publication about the use of CRISPR/Cas9 to edit the genome of human embryos, the journal Nature published two articles. There was a brief commentary “Don’t edit the human germ line” calling for a voluntary moratorium on germline modification, and a news item “Scientists sound alarm over DNA editing of human embryos” explaining that while some scientists want to ban germline alterations, others want the work to proceed. The anticipated study confirming the use of gene-editing techniques to modify the human germline was published online in April 2015. Various media outlets reported on this research and the Science Media Centre published the views of various “experts” on this development – some saying it should be allowed, others saying it should not be allowed.
Various commentators, including the authors of “Don’t edit the human germ line” have called for an open public discussion. I find this commendable...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...